ArticleSurgical endoscopy2025
Surgical outcomes of conventional versus indocyanine green fluorescence-guided laparoscopic cholecystectomy in acute cholecystitis: a propensity score-matched analysis.
Article in Surgical endoscopy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Does ICG-NIRF cholangiography replace the critical view of safety in laparoscopic cholecystectomy? A prospective evaluation on biliary visualization dynamics and the impact of inflammation.Surgical endoscopy · 2026Article
- Article
- Indocyanine green fluorescence navigation for extrahepatic bile duct visualization in laparoscopic cholecystectomy: a prospective cohort study.Annals of medicine and surgery (2012) · 2026Article
- Surgical outcomes of indocyanine green fluorescent cholangiography in emergency laparoscopic cholecystectomy performed by junior surgeons for acute cholecystitis.Frontiers in surgery · 2026Article
- Association of indocyanine green fluorescence navigation with extrahepatic biliary anatomy identification and operative efficiency in laparoscopic cholecystectomy: a retrospective cohort study.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionEarly laparoscopic cholecystectomy remains the gold standard for managing acute cholecystitis. Intraoperative fluorescent cholangiography using indocyanine green (ICG) has emerged as a promising technique to enhance surgical safety by improving visualization of biliary anatomy, reducing bile duct injuries, and decreasing the incidence of failed critical view of safety (CVS), thereby minimizing the need for bailout procedures. This study aimed to compare surgical outcomes, particularly the need for bailout procedures, between conventional (white-light) and ICG fluorescence-guided laparoscopic cholecystectomy in patients with acute cholecystitis.
methodsA prospective cohort of patients undergoing ICG fluorescence-guided laparoscopic cholecystectomy (n = 101, January 2023 - December 2024) was compared with a retrospective control group treated with conventional laparoscopic cholecystectomy (n = 84, January 2021 - December 2022) at the same institution. Propensity score matching (1:1 ratio) was employed to minimize selection bias and confounding variables.
resultsPatients in the fluorescence-guided group had a significantly lower rate of bailout procedures compared to the conventional group. No statistically significant differences were observed between the groups in secondary outcomes, including operative time, length of hospital stay, reintervention rates, and major complications (Clavien-Dindo grade ≥ III). Binary logistic regression confirmed a significant reduction in the risk of bailout procedures with fluorescence guidance (OR = 0.05; 95% CI: 0.00-0.33), while no other covariates reached statistical significance.
conclusionBased on our findings, the use of ICG fluorescence was associated with a reduced need for bailout procedures. Further multicenter prospective studies are necessary to validate these results and assess long-term outcomes.
Indexed as
Identifiers
40571795What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.